Kodiak Sciences Inc.

KOD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016
Operating Activities
Net Income $-27.9M $-17.1M
Depreciation & Amortization — —
Depreciation $549.0K $257.0K
Amortization — —
Stock-Based Compensation $275.0K $272.0K
Net Cash from Operating Activities $-17.7M $-16.0M
Investing Activities
Capital Expenditures $209.0K $771.0K
Business Acquisitions — —
Net Cash from Investing Activities $-209.0K $-771.0K
Financing Activities
Dividends Paid — —
Stock Repurchases $0 $4.0K
Net Cash from Financing Activities $9.6M $-120.0K
Net Change in Cash — —
Free Cash Flow $-17.9M $-16.8M
← Newer Page 2 of 2 Older →